Hong Kong Island, Hong Kong, China Related Funds
| Fund Name | Location |
| Arcadian Investment Partners | New York, New York, United States |
| Bank El Etihad | Amman, Amman, Jordan |
| Be Angels | Belgium, Louvain-la-neuve, Vlaams-Brabant |
| CDL China | China, Hong Kong, Hong Kong Island |
| China Environmental Technology and Bioenergy Holdings | China, Hong Kong, Kowloon |
| EnerNOC | Boston, Massachusetts, United States |
| Food+Tech Connect | New York, New York, United States |
| Funds managed by Maj Invest | - |
| Huitianxi Touzi | China, Fujian, Xiamen |
| Humanwell | China, Hubei, Wuhan |
| Huobi Eco | Beijing, Beijing, China |
| Ju Shi Chuang Tou | China, Jiangsu, Nanjing |
| KSD Advisory | Frankfurt, Germany, Hessen |
| Mentor Partners | Bangalore, India, Karnataka |
| N29 Capital Partners | Manitowish Waters, United States, Wisconsin |
| pcorder.com | Austin, Texas, United States |
| Siddhivinayak Skyscrapers | - |
| The Moinian Group | New York, New York, United States |
| WANDA Group | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GluBio Pharmaceutical | $50M | 28 Feb 2022 | Hangzhou, Zhejiang, China | ||
MicroPort CRM | $150M | 26 Jul 2021 | Clamart, Ile-de-France, France | ||
RecBio | $154M | 14 Jun 2021 | Taizhou, Jiangsu, China | ||
Qulian Technology | $15M | 30 Apr 2021 | Shangcheng District, Zhejiang, China | ||
Jinqirui Biology | $15M | 25 Dec 2020 | Huangpu, Shanghai, China | ||
| $18M | 09 Jul 2015 | Siming, Fujian |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GluBio Pharmaceutical | $50M | 28 Feb 2022 | Hangzhou, Zhejiang, China | ||
MicroPort CRM | $150M | 26 Jul 2021 | Clamart, Ile-de-France, France | ||
RecBio | $154M | 14 Jun 2021 | Taizhou, Jiangsu, China | ||
Qulian Technology | $15M | 30 Apr 2021 | Shangcheng District, Zhejiang, China | ||
Jinqirui Biology | $15M | 25 Dec 2020 | Huangpu, Shanghai, China | ||
| $18M | 09 Jul 2015 | Siming, Fujian |
